ArticleInternational journal of hematology2025

Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia.

Atsushi Kohso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.